Capital Flow Monitor · Sponsors · CIK 2071562

IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P.

C/O COMPLIANCE DEPARTMENT, NEW YORK, NY, 10165 · 2129947400

Pooled Investment Fund / Private Equity Fund · Limited Partnership· inc. DELAWARE true 2025

Fit score

—

Offering

—

Sold

$26.5M

% sold

—

Investors

11

Min investment

$0

Exemption

506(c)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2026-07-21 D/A ·current 506(c) — $26.5M — 11 EDGAR ↗
2025-07-14 D 506(c) — $0 — 0 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.